Financials

  • Market Capitalization 2.52 B
  • Employee 177
  • Founded 2006
  • CEO N/A
  • Website www.immunome.com
  • Headquarter Delaware, United States
  • FIGI BBG00BR93ZG8
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-9.15
Relación precio/flujo de caja
112.46

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1794
KOD
Kodiak Sciences Inc - Common Stock
41.50 USD-4.07%+2.72%+21.74%+753.91%2.60 B USD
1821
QURE
uniQure N.V. - Ordinary Shares
41.13 USD-0.94%-4.90%+48.32%+192.32%2.59 B USD
1845
TRVI
Trevi Therapeutics, Inc. - Common Stock
17.61 USD-1.68%-8.52%+20.04%+156.71%2.50 B USD
1856
SLS
SELLAS Life Sciences Group, Inc. - Common Stock
13.60 USD+1.57%-6.98%+78.95%+608.33%2.53 B USD

Noticias